The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 31, 2023

Filed:

Feb. 09, 2019
Applicant:

Foundry Innovation & Research 1, Ltd., Dublin, IE;

Inventors:

Hanson S. Gifford, III, Woodside, CA (US);

Mark E. Deem, Portola Valley, CA (US);

Conor M. Hanley, Dublin, IE;

Fiachra M. Sweeney, Dublin, IE;

Jeffry J. Grainger, Portola Valley, CA (US);

John R. Britton, Dublin, IE;

Annette Kent, Dublin, IE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/107 (2006.01); A61B 5/00 (2006.01); A61B 8/08 (2006.01); A61B 8/12 (2006.01); A61B 5/0205 (2006.01); A61B 5/07 (2006.01); A61B 8/00 (2006.01); A61B 5/024 (2006.01); A61B 5/021 (2006.01); A61B 5/0215 (2006.01);
U.S. Cl.
CPC ...
A61B 5/1076 (2013.01); A61B 5/0205 (2013.01); A61B 5/076 (2013.01); A61B 5/4839 (2013.01); A61B 5/4875 (2013.01); A61B 5/6876 (2013.01); A61B 5/746 (2013.01); A61B 8/0891 (2013.01); A61B 8/12 (2013.01); A61B 8/5223 (2013.01); A61B 8/5292 (2013.01); A61B 8/56 (2013.01); A61B 5/021 (2013.01); A61B 5/024 (2013.01); A61B 5/0215 (2013.01); A61B 5/6882 (2013.01); A61B 8/4472 (2013.01);
Abstract

Systems and methods are disclosed that provide for regular, periodic or continuous monitoring of fluid volume based on direct measurement of an inferior vena cava (IVC) physical dimension using a wireless measurement sensor implanted in the IVC. By basing diagnostic decisions and treatments on changes in an IVC physical dimension, information on patient fluid state is available across the entire euvolemic range of fluid states, thus providing earlier warning of hypervolemia or hypovolemia and enabling the modulation of patient treatments to permit more stable long-term fluid management.


Find Patent Forward Citations

Loading…